News
METHODOLOGY: The numbers on this page are calculated from contributions of more than $200 from individuals, as reported to the Federal Election Commission. PAC dollars are not included. NOTE: All the ...
Hosted on MSN15d
'I Think It's So Vital': Tom Cotton Questions Trump Nominee During Confirmation HearingDuring his remarks in a Senate hearing this week, Senator Tom Cotton questioned Trump's nominee to be Assistant Secretary Of Defense For Cyber Policy, Katherine Sutton. Trump administration ...
“By identifying opportunities to bring in stable revenue, we believe the Company can reduce its need for capital that could be dilutive to the stock price,” Latkin said. The real estate ...
Bombay Cotton Exchange Company Limited is a Non-govt company. It's a public unlisted company and is classified as'company limited by guarantee'. Company's authorized capital stands at Rs 0.0 lakhs and ...
An industrial gas company has delayed the startup of its $8 billion blue hydrogen and carbon capture and storage (CCS) project in the US until it is able to divest certain elements of the effort. An ...
UNITY Biotechnology, Inc. has announced that it ... interested in age-related ophthalmic and neurologic conditions. The company cautioned that forward-looking statements made in the release ...
During an April 30 webinar about the top-line results, Immunic CEO Daniel Vitt, Ph.D., dismissed the primary endpoint, saying the measure had fallen behind current scientific advancements. "Nobody ...
Hosted on MSN21d
Tom Cotton Discusses The Nomination Of Warren Stephan To Be Next Ambassador To The United KingdomDuring his remarks from the Senate floor today, Senator Tom Cotton urged his colleagues to support the nomination of Warren Stephan to be the United States' next ambassador to the United Kingdom.
Novartis will pay $800 million upfront to acquire Regulus Therapeutics, a San Diego biotechnology company that launched nearly two decades ago with plans to make drugs capable of targeting small ...
an advanced preclinical-stage biotechnology company focused on developing and commercializing therapeutics for neurogenetic developmental diseases, today announces the acquisition of Alpha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results